EDITORIAL: "Key Challenges for Successful Partnerships"
HOW YOU CAN HELP DNDi?
DNDi's Malaria Project: A Model for Innovative Partnerships?
Fighting Malaria in the Legal Amazon, Brazil
ASMQ in a Nutshell
ASAQ: a new Business Model for a "Big Pharma"
ASMQ: a Great Public-Private, Intercontinental Partnership
Why Lead Platforms are Crucial to Boost Innovation for Neglected Diseases
Asian Region Makes Use of its Biodiversity to Identify New Bioactive Molecules
Our moral responsibility to address Public Health Issues
Four Characteristics For Partnership
Paving the Way to Win-Win Partnerships
DNDi R&D Projects-2008 Outlook
Synergise Efforts with Anacor, GSK, IRD, Eskitis, UNC, and Intitut Pasteur Korea.
Operational Challenges: Clinical Trial Partnerships in Africa
LEAP: 4 Years and Going Strong...
Concentrated HAT Platform Efforts in the 5 Most Affected Countries
Advances at the DNDi Regional Support Office KEMRI, Nairobi
Actions to Increase Awareness and Visibility in the Asian Region
DNDi's Launch of ASMQ in Rio de Janeiro
DNDi Project Collaboration in Japan
DNDi in DRC brings Regular Support to the Clinical Trials
From Discovery to Clinical Trials in India
DNDi Strengthens North American Presence
DNDi Joins Scientists Without Borders
Fexinidazole: A Rediscovered Compound Progresses as a Preclinical Drug Candidate for HAT
Neglected by Everybody: PLoS NTD Publishes Media Analysis on Neglected Diseases
DNDi Participates at International Meeting on Chagas Disease
DNDi Awarded by the French Societé de Pathologie Exotique
DNDi Receives Goodwin Award for Its Social Entrepeneurial Approach for the Most Neglected
Diversifying Sources of Funding
News from Donors
IGWG: An Important Step Towards Boosting Innovation
For any further information, please contact our communication department:
Published by Drugs for Neglected Diseases Initiative - 15 Chemin Louis-Dunant 1202 Geneva Switzerland - Photo credits: DNDi unless otherwise stated - Editor: Sadia Kaenzig - Tel: +41 22 906 9230 - Fax: +41 22 906 9231 - www.dndi.org